DNA patents and diagnostics: not a pretty picture.
作者信息
Carbone Julia, Gold E Richard, Sampat Bhaven, Chandrasekharan Subhashini, Knowles Lori, Angrist Misha, Cook-Deegan Robert
机构信息
Duke University's School of Law, Durham, North Carolina, USA.
出版信息
Nat Biotechnol. 2010 Aug;28(8):784-91. doi: 10.1038/nbt0810-784.
Abstract
摘要
相似文献
1
DNA patents and diagnostics: not a pretty picture.
Nat Biotechnol. 2010 Aug;28(8):784-91. doi: 10.1038/nbt0810-784.
2
Ownership at too high a price?
Nat Biotechnol. 2003 Sep;21(9):953. doi: 10.1038/nbt0903-953.
3
[Federal judge and government of the United States against gene patenting].
Med Sci (Paris). 2011 Jun-Jul;27(6-7):662-6. doi: 10.1051/medsci/2011276020. Epub 2011 Jul 1.
4
Biotechs sue Columbia over fourth Axel patent.
Nat Biotechnol. 2003 Sep;21(9):955-6. doi: 10.1038/nbt0903-955.
5
Gene patents in the dock.
Nature. 2013 Apr 11;496(7444):150. doi: 10.1038/496150a.
6
Intellectual property. Supreme Court rules out patents on 'natural' genes.
Science. 2013 Jun 21;340(6139):1387-8. doi: 10.1126/science.340.6139.1387.
7
Diagnostics firms face new patent claim worries.
Nat Biotechnol. 2009 Jul;27(7):586-7. doi: 10.1038/nbt0709-586c.
8
Bungled law threatens Italian tech transfer.
Nat Biotechnol. 2001 Nov;19(11):996-7. doi: 10.1038/nbt1101-996.
9
Genes can't be patented, rules Supreme Court.
BMJ. 2013 Jun 14;346:f3907. doi: 10.1136/bmj.f3907.
10
The impact of patenting on DNA diagnostic practice.
Clin Med (Lond). 2008 Feb;8(1):58-60. doi: 10.7861/clinmedicine.8-1-58.
引用本文的文献
1
Are the gene-patent storm clouds dissipating? A global snapshot.
Nat Biotechnol. 2015 Apr;33(4):347-52. doi: 10.1038/nbt.3182.
2
Distributing the future: The weak justifications for keeping human genomic databases secret and the challenges and opportunities in reverse engineering them.
Appl Transl Genom. 2014 Dec 1;3(4):124-127. doi: 10.1016/j.atg.2014.09.005.
3
Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga.
Curr Pharmacogenomics Person Med. 2013 Jun;11(2):98-109. doi: 10.2174/1875692111311020003.
4
Commercial landscape of noninvasive prenatal testing in the United States.
Prenat Diagn. 2013 Jun;33(6):521-31. doi: 10.1002/pd.4101.
5
Molecular genetic testing and the future of clinical genomics.
Nat Rev Genet. 2013 Jun;14(6):415-26. doi: 10.1038/nrg3493.
6
Harm, hype and evidence: ELSI research and policy guidance.
Genome Med. 2013 Mar 26;5(3):21. doi: 10.1186/gm425. eCollection 2013.
7
Biomarker patents for diagnostics: problem or solution?
Nat Biotechnol. 2012 Jun 7;30(6):498-500. doi: 10.1038/nbt.2257.
8
The fate and future of patents on human genes and genetic diagnostic methods.
Nat Rev Genet. 2012 May 18;13(6):441-8. doi: 10.1038/nrg3255.
9
Human DNA patent renewals on the decline.
Nat Biotechnol. 2011 Aug 5;29(8):711-3. doi: 10.1038/nbt.1930.
10
Anchoring gene patent eligibility to its constitutional mooring.
Nat Biotechnol. 2010 Dec;28(12):1251-5. doi: 10.1038/nbt.1728.
本文引用的文献
1
Spinocerebellar ataxia: patient and health professional perspectives on whether and how patents affect access to clinical genetic testing.
Genet Med. 2010 Apr;12(4 Suppl):S83-S110. doi: 10.1097/GIM.0b013e3181d67e44.
2
Impact of gene patents and licensing practices on access to genetic testing for Alzheimer disease.
Genet Med. 2010 Apr;12(4 Suppl):S71-82. doi: 10.1097/GIM.0b013e3181d5a68e.
3
Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.
Genet Med. 2010 Apr;12(4 Suppl):S5-S14. doi: 10.1097/GIM.0b013e3181d5a669.
4
Myriad Genetics: In the eye of the policy storm.
Genet Med. 2010 Apr;12(4 Suppl):S39-70. doi: 10.1097/GIM.0b013e3181d72661.
5
Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis.
Genet Med. 2010 Apr;12(4 Suppl):S194-211. doi: 10.1097/GIM.0b013e3181d7cf7d.
6
Impact of gene patents and licensing practices on access to genetic testing for hearing loss.
Genet Med. 2010 Apr;12(4 Suppl):S171-93. doi: 10.1097/GIM.0b013e3181d7b053.
7
Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis.
Genet Med. 2010 Apr;12(4 Suppl):S155-70. doi: 10.1097/GIM.0b013e3181d7acb0.
8
Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers.
Genet Med. 2010 Apr;12(4 Suppl):S15-38. doi: 10.1097/GIM.0b013e3181d5a67b.
9
Impact of gene patents and licensing practices on access to genetic testing for long QT syndrome.
Genet Med. 2010 Apr;12(4 Suppl):S111-54. doi: 10.1097/GIM.0b013e3181d68293.
10
Legal uncertainty in the area of genetic diagnostic testing.
Nat Biotechnol. 2009 Oct;27(10):903-9. doi: 10.1038/nbt1009-903.
Zotero 插件